Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Ro

Men Genetically Prone to Baldness Carry a 7 Percent Added Hair Loss Risk Tied to GLP-1 Biology

An NYU Langone genetic study links GLP-1 receptor activity to a 7 percent increased risk of male pattern hair loss. What the finding does and does not show.

Medical Daily

Chrissy Metz Weight Loss: This Is Us Star Embraces GLP-1 Treatment After Years Of Scepticism

Chrissy Metz shares her journey with GLP-1 weight loss medication, highlighting its benefits for her health and mobility, while addressing public judgement and emphasising a holistic lifestyle change

International Business Times UK

‘It is okay not to be okay’: NFL legend Terrell Davis joins growing roster of athletes partnering with big pharma to raise health awareness

The hall-of-famer has partnered with Teva to raise awareness on Tardive Dyskinesia, a chronic movement disorder. He’s in good company with Serena & co.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

Serena Williams sprinkles stardust at Wimbledon with top female players toiling

Her motivations for returning may be hard to gauge but there is no doubt the returning former champion will steal the early spotlight at SW19

The Guardian - UK

Is the growing use of GLP-1s reshaping ideas of Black beauty?

People across the Black diaspora are increasingly turning to weight-loss drugs. How might this reshape our health, wellbeing and body image?

The Guardian - UK

Serena Williams confirms stunning return to tennis ahead of Wimbledon at age of 44

Williams will begin her ‘next chapter’ by playing doubles at Queen’s Club, ahead of possibly competing in singles at Wimbledon

The Independent UK

RFK Jr.'s peptide push could become next wellness boom

The heavily touted but loosely regulated proteins could fuel the kind of boom we've seen with weight-loss drugs.

Axios

Read news from The Economist, FT, and more,
with one subscription

Tennis Mailbag: What a Potential Serena Williams Comeback Could Look Like

The 44-year-old has been coy about a possible return to the sport despite her name appearing on the ITIA’s reinstatement list.

Sports Illustrated

Serena Williams Slammed Over ‘Disgusting’ Super Bowl Ad Amid Controversial Weight Loss Transformation

“Why is she doing that with all the money in the bank; how sad is that for a famous woman.”

Bored Panda

George Clooney and Kendall Jenner to feature in Super Bowl ads as off-field battle heats up

Over 120 million viewers will tune in for this weekend’s Super Bowl between the Seattle Seahawks and the New England Patriots

The Independent UK

“The Knees Are Kneeing”: Serena Williams Leaves Fans Stunned With Viral Jaw-Dropping Move

“I ain’t sorry, these Meg knees are here to stay,” Serena Williams wrote

Bored Panda

Novo Nordisk Is Getting a Major Boost from Amazon for Its New Wegovy Pill. Does That Make NVO Stock a Buy Here?

Novo Nordisk shares inch higher as the pharma giant announces an oral Wegovy partnership with Amazon Pharmacy. Here’s why NVO stock is worth owning at current levels.

Barchart

'I've seen so many doctors' - Thalita de Jong looking forward to 2026 after year plagued by medical mystery

Former cyclocross world champion aiming for incident free season with Human Powered Health

Cycling News

Soft2Bet fuses social media and iGaming experience in Romania

Swiper brings social media-style betting.

Dot Esports

Get all your
news in one place.

100's of premium titles.
One news app.

Bored Panda

Heated Reactions After Serena Williams Calls Out NYC Hotel Over Cotton Plant Decoration

"How do we feel about cotton as decoration?" the tennis star asked her followers.

Woman & Home

How do weight loss jabs work? Dr Amir Khan reveals all you need to know

Whether you know Mounjaro from Wegovy or it's all Ozempic to you, you'd have to be living (blissfully) under a rock to miss the chatter about weight loss jabs

BANG Premier

Jameela Jamil slams Serena Williams over weight-loss medication use

Jameela Jamil finds it "uncomfortable" seeing Serena Williams promote the use of weight-loss medication.

The Independent UK

Voices: Serena Williams’s GLP-1 partnership marks a disturbing cultural turning point

COMMENT: As a Black woman in a white-dominated sport, Williams experienced unique pressures. Yet to see someone of her calibre promoting weight-loss drugs shows an unnerving societal shift, writes the body image campaigner Alex Light

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

Serena Williams built her legacy on defiance. Why lend it to Ozempic culture?

From Compton outsider to American nonpareil, she came to embody resistance. But her embrace of GLP-1 drugs feels like capitulation to ideals she once rejected

Euronews

Serena Williams reveals GLP-1 treatment helped her lose 31 pounds after giving birth

After years of struggling with postpartum weight gain despite strict training and healthy eating, the 23-time Grand Slam champion turned to a GLP-1 medication.

Marie Claire

Serena Williams's Take on Fall 2025's Wide-Leg Trouser Trend Belongs in the US Open Stands

She served an off-court look miles away from the tennis courts.

Marie Claire

Serena Williams Being Open About Using a GLP-1 Is Exactly the News I Wanted to See Today

The weight loss conversation is shifting.

Benzinga

From Taboo To Tech: Fellow Health's $24M Raise Signals Big Shift In Men's Reproductive Health

Fellow Health just raised $24 million in a Series B funding round, bringing its cash haul across multiple offerings to $48 million. The San Leandro, California startup advances male reproductive health through "patient-centric testing solutions" and plans to use the capital infusion to expand its mail-in semen analysis services.

Al Jazeera

Folk music and raids: How ultranationalists target migrants in Russia

The Russian Community group has soared in popularity, with its focus on promoting the needs of ‘ethnic Russians’.

International Business Times UK

Why Did Novo Nordisk Pull the Plug on Hims Collaboration?

Novo Nordisk ended its partnership with Hims & Hers on 23 June 2025, accusing the telehealth firm of selling unsafe, unapproved Wegovy knock-offs. Hims' stock tanked, and legal risks loom.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.